A significant shift in Canadian drug policy has happened, as the authorities permit the legalization of psilocybin mushrooms for therapeutic applications. Before this, these substances were heavily restricted, but a increasing body of studies suggests they potentially offer relief for emotional illnesses like anxiety. This development represents a